Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Fig. 2

Survival curves representing prognostic factors associated with better survival in patients treated with chemotherapy. a shows the better survival for patients with ECOG-PS 0-1 vs ECOG-PS 2-3 (p=0.007). b shows that patients who presented disease control with first-line sorafenib had better survival versus those with progressive disease with sorafenib. (p=0.003)

Back to article page